External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic.

van Nieuwland, Marieke; van Bon, Lenny; Vermeer, Marloes; Brouwer, Elisabeth; Alves, Celina

van Nieuwland, Marieke; van Bon, Lenny; Vermeer, Marloes; Brouwer, Elisabeth; Alves, Celina.

Afiliación

van Nieuwland M; Department of Rheumatology and Clinical Immunology, Ziekenhuisgroep Twente (Hospital Group Twente), Almelo, The Netherlands m.vnieuwland@zgt.nl.
van Bon L; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Vermeer M; Department of Rheumatology and Clinical Immunology, Ziekenhuisgroep Twente (Hospital Group Twente), Almelo, The Netherlands.
Brouwer E; ZGT Academy, Ziekenhuisgroep Twente (Hospital Group Twente), Almelo, The Netherlands.
Alves C; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

RMD Open ; 9(3)2023 07.

Article en En | MEDLINE | ID: mdl-37507207

Asunto(s)

Arteritis de Células Gigantes; Humanos; Arteritis de Células Gigantes/diagnóstico; Arterias Temporales; Estudios Prospectivos; Sensibilidad y Especificidad; Curva ROC

Palabras clave

Epidemiology; Giant Cell Arteritis; Systemic vasculitis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Arteritis de Células Gigantes Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: RMD Open Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google